69 results
DEFR14A
ACET
Adicet Bio Inc
26 Apr 24
Revised proxy
4:13pm
by our Audit Committee or the engagement is entered into pursuant to the pre-approval procedure described below.
From time to time, our Audit Committee
PRE 14A
ACET
Adicet Bio Inc
12 Apr 24
Preliminary proxy
5:23pm
by our Audit Committee or the engagement is entered into pursuant to the pre-approval procedure described below.
From time to time, our Audit
8-K
egmf2v7r
12 Nov 21
Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
7:18am
8-K
EX-99.1
689tv4i8z
12 Nov 21
Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting
7:18am
8-K
EX-99.1
cocv7
10 Nov 21
Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates
4:12pm